Advertisement
GMED vs IRMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Buy and IRMD is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GMED’s FA Score shows that 0 FA rating(s) are green whileIRMD’s FA Score has 2 green FA rating(s).
- GMED’s FA Score: 0 green, 5 red.
- IRMD’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GMED’s TA Score shows that 4 TA indicator(s) are bullish while IRMD’s TA Score has 4 bullish TA indicator(s).
- GMED’s TA Score: 4 bullish, 5 bearish.
- IRMD’s TA Score: 4 bullish, 5 bearish.
Price Growth
GMED (@Medical/Nursing Services) experienced а -5.19% price change this week, while IRMD (@Medical/Nursing Services) price change was -4.16% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.38%. For the same industry, the average monthly price growth was -2.45%, and the average quarterly price growth was +13.17%.
Reported Earning Dates
GMED is expected to report earnings on Feb 19, 2026.
IRMD is expected to report earnings on Apr 30, 2026.
Industries' Descriptions
@Medical/Nursing Services (+3.38% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| GMED | IRMD | GMED / IRMD | |
| Capitalization | 11.7B | 1.19B | 982% |
| EBITDA | 710M | 25.8M | 2,752% |
| Gain YTD | -0.286 | -3.526 | 8% |
| P/E Ratio | 28.17 | 56.76 | 50% |
| Revenue | 2.77B | 80.5M | 3,441% |
| Total Cash | 391M | N/A | - |
| Total Debt | 119M | 0 | - |
GMED | IRMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 59 Fair valued | |
PROFIT vs RISK RATING 1..100 | 69 | 12 | |
SMR RATING 1..100 | 70 | 40 | |
PRICE GROWTH RATING 1..100 | 43 | 42 | |
P/E GROWTH RATING 1..100 | 99 | 22 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRMD's Valuation (59) in the Medical Specialties industry is in the same range as GMED (74). This means that IRMD’s stock grew similarly to GMED’s over the last 12 months.
IRMD's Profit vs Risk Rating (12) in the Medical Specialties industry is somewhat better than the same rating for GMED (69). This means that IRMD’s stock grew somewhat faster than GMED’s over the last 12 months.
IRMD's SMR Rating (40) in the Medical Specialties industry is in the same range as GMED (70). This means that IRMD’s stock grew similarly to GMED’s over the last 12 months.
IRMD's Price Growth Rating (42) in the Medical Specialties industry is in the same range as GMED (43). This means that IRMD’s stock grew similarly to GMED’s over the last 12 months.
IRMD's P/E Growth Rating (22) in the Medical Specialties industry is significantly better than the same rating for GMED (99). This means that IRMD’s stock grew significantly faster than GMED’s over the last 12 months.
| GMED | IRMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 54% | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 64% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 60% | 1 day ago 59% |
| MACD ODDS (%) | 1 day ago 61% | 1 day ago 53% |
| TrendWeek ODDS (%) | 1 day ago 57% | 1 day ago 58% |
| TrendMonth ODDS (%) | 1 day ago 58% | 1 day ago 63% |
| Advances ODDS (%) | 15 days ago 65% | 15 days ago 75% |
| Declines ODDS (%) | 1 day ago 57% | 1 day ago 54% |
| BollingerBands ODDS (%) | 1 day ago 58% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 58% | 1 day ago 79% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IPMIX | 22.21 | 0.18 | +0.82% |
| Voya Index Plus MidCap Port I | |||
| SPMWX | 9.55 | 0.04 | +0.39% |
| Invesco SteelPath MLP Select 40 R | |||
| PRVRX | 12.98 | 0.04 | +0.31% |
| PGIM Quant Solutions Large-Cap Val R | |||
| DGSCX | 38.34 | 0.07 | +0.18% |
| Virtus KAR Global Small-Cap Inst | |||
| MXKWX | 10.70 | N/A | N/A |
| Empower S&P 500® Index Institutional | |||
GMED and
Correlation & Price change
A.I.dvisor indicates that over the last year, GMED has been closely correlated with SENS. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if GMED jumps, then SENS could also see price increases.
| Ticker / NAME | Correlation To GMED | 1D Price Change % | ||
|---|---|---|---|---|
| GMED | 100% | -0.45% | ||
| SENS - GMED | 71% Closely correlated | +1.40% | ||
| PAVM - GMED | 68% Closely correlated | +7.21% | ||
| AXGN - GMED | 67% Closely correlated | -2.81% | ||
| MOVE - GMED | 66% Loosely correlated | +4.87% | ||
| INBS - GMED | 64% Loosely correlated | -6.14% | ||
More | ||||
IRMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with GMED. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then GMED could also see price increases.
| Ticker / NAME | Correlation To IRMD | 1D Price Change % | ||
|---|---|---|---|---|
| IRMD | 100% | -4.22% | ||
| GMED - IRMD | 61% Loosely correlated | -0.45% | ||
| MOVE - IRMD | 59% Loosely correlated | +4.87% | ||
| CERS - IRMD | 54% Loosely correlated | -2.14% | ||
| AXGN - IRMD | 51% Loosely correlated | -2.81% | ||
| PEN - IRMD | 49% Loosely correlated | -4.52% | ||
More | ||||